Amgen Makes £50M Investment In Genetic Sequencing Co.
Amgen Inc. is making a £50 million ($66 million) equity investment in U.K.-based Oxford Nanopore Technologies Ltd., which develops gene sequencing technology for its handheld and laboratory-grade devices, the companies said...To view the full article, register now.
Already a subscriber? Click here to view full article